Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial.
Journal: The American journal of gastroenterology
Published: June 04, 2024
Small-Molecule Neutrophil Modulator ADS051 is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study.
Journal: The American journal of gastroenterology
Published: June 04, 2024
Building the Case: Changing Consumer Perceptions of the Value of Expanded Community Pharmacist Services.
Journal: Journal of pharmacy practice
Published: May 15, 2018
Showing 1-4 of 4
Last Updated: 09/26/2026